Top Stories
The Neuralink competitor has raised $430 million in total as it works to commercialise its wireless BCI system.
The deal follows a $787-million financing for Earendil, backed by Sanofi and Pfizer.
Amgen, Lilly and Merck & Co. are among the investors backing the biotech's agentic data platform for rapid protein design.
Several panellists expressed "serious concerns" about whether Galleri has demonstrated a clinical benefit.
UltraSight wants AI-guided scanning to become part of daily workflows across multiple care settings rather than remain a single-unit pilot, CEO Davidi Vortman told FirstWord.
Conference News
DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Oral presentation of the results from the RAMP 201J study of avutometinib plus defactinib in recurrent LGSOC in Japanese patientsNew external control arm analysis of avutometinib plus defactinib versu...
Hyperion will offer digital demos of the company’s IVY™ solution, designed to address the high variability and failure rate in difficult-to-access IV placementsWe look forward to demonstrating how IVY...
Rapid Oral presentation will report initial Phase I data for ISM6331 in patients with advanced solid tumorsFDA Fast Track- and Orphan Drug-designated program reflects Insilico’s strategy to advance AI...
The company lined up for an IPO the same day it signed an AI drug discovery deal with AbbVie.
